Zydus launches biosimilar Denosumab 120 mg SC – protecting bone health in cancer patients
Ahmedabad, Dec 11: Zydus Lifesciences Ltd., an innovation-led healthcare company, with an international presence has launched ‘Zyrifa’, a Denosumab biosimilar.…
